Publications by authors named "Dimitrios Roukos"

Claim this Profile
C
Combination therapy in neoadjuvant and metastatic settings in hot tumors: strengths and weaknesses.
Elena X Stea, Georgios K Glantzounis, Efstathios G Lykoudis, Dimitrios H Roukos

Expert Rev Anticancer Ther· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular deciphering of melanoma: advances and challenges of neoadjuvant and perioperative treatment.
Elena X Stea, Georgios K Glantzounis, Nikolaos Kydonakis, Dimitrios H Roukos

Expert Rev Mol Diagn· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal ctDNA profiling in precision oncology and immunο-oncology.
Panagiotis Filis, Ioannis Kyrochristos, Efterpi Korakaki, Evangelos G Baltagiannis, Dimitris Thanos, Dimitrios H Roukos

Drug Discov Today· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proof-of-Concept Pilot Study on Comprehensive Spatiotemporal Intra-Patient Heterogeneity for Colorectal Cancer With Liver Metastasis.
Ioannis D Kyrochristos, Georgios K Glantzounis, Anna Goussia, Alexia Eliades, Achilleas Achilleos, Dimitrios Roukos

Front Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor heterogeneity-driven individualized therapy.
Evangelos G Baltagiannis, Demosthenis E Ziogas, William C Cho, Michail Mitsis, Dimitrios H Roukos

Future Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From personalized to precision cancer medicine.
Evangelos G Baltagiannis, Ioannis D Kyrochristos, Demosthenes E Ziogas, Anna Goussia, Michail Mitsis, Dimitrios H Roukos

Per Med· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision in cancer pharmacogenomics.
Ioannis D Kyrochristos, Evangelos G Baltagiannis, Michail Mitsis, Dimitrios H Roukos

Pharmacogenomics· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive and patient-monitoring biomarkers: precision in the management of colorectal cancer.
Georgios Pappas-Gogos, Evangelos G Baltagiannis, Ioannis D Kyrochristos, Demosthenes E Ziogas, Anna Goussia, Dimitrios H Roukos

Biomark Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive intra-individual genomic and transcriptional heterogeneity: Evidence-based Colorectal Cancer Precision Medicine.
Ioannis D Kyrochristos, Dimitrios H Roukos

Cancer Treat Rev· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bulk and Single-Cell Next-Generation Sequencing: Individualizing Treatment for Colorectal Cancer.
Ioannis D Kyrochristos, Demosthenes E Ziogas, Anna Goussia, Georgios K Glantzounis, Dimitrios H Roukos

Cancers (Basel)· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic and transcriptional heterogeneity-based precision in personalized treatment for breast cancer.
Persefoni Antoniou, Demosthenes E Ziogas, Aikaterini Vlachioti, Eustathios G Lykoudis, Michail Mitsis, Dimitrios H Roukos

Per Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug resistance: origins, evolution and characterization of genomic clones and the tumor ecosystem to optimize precise individualized therapy.
Ioannis D Kyrochristos, Demosthenes E Ziogas, Dimitrios H Roukos

Drug Discov Today· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision oncology in patients with nonmetastatic disease: emerging reality or illusion.
Persefoni Antoniou, Demosthenes E Ziogas, Michail Mitsis, Dimitrios H Roukos

Future Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic genome and transcriptional network-based biomarkers and drugs: precision in breast cancer therapy.
Ioannis D Kyrochristos, Demosthenes E Ziogas, Dimitrios H Roukos

Med Res Rev· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovering novel valid biomarkers and drugs in patient-centric genomic trials: the new epoch of precision surgical oncology.
Demosthenes E Ziogas, Ioannis D Kyrochristos, Dimitrios H Roukos

Drug Discov Today· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breakthrough cancer genome analysis in time and space: novel oncotargets and early drug development.
Ioannis D Kyrochristos, Demosthenes E Ziogas, Persefoni Antoniou, Michail Mitsis, Efstathios G Lykoudis, Dimitrios H Roukos

Pharmacogenomics· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early solid tumor diagnosis through next-generation sequencing of cell-free DNA.
Demosthenes E Ziogas, Ioannis D Kyrochristos, Efstathios G Lykoudis, Dimitrios H Roukos

Biomark Med· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision in personalized prediction-based medicine.
Ioannis D Kyrochristos, Demosthenes E Ziogas, Dimitrios H Roukos

Per Med· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precise predictive and therapeutic strategy for breast cancer.
Ioannis D Kyrochristos, Dimitra V Peristeri, Demosthenes E Ziogas, Efstathios G Lykoudis, Dimitrios H Roukos

Future Oncol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer genome analysis in time and space: biomarker development strategy.
Ioannis D Kyrochristos, Demosthenes E Ziogas, Efstathios G Lykoudis, Dimitrios H Roukos

Biomark Med· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of pancreatic cancer risk and therapeutic response with next-generation sequencing.
Ioannis D Kyrochristos, Demosthenes E Ziogas, Georgios K Glantzounis, Dimitrios H Roukos

Biomark Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-generation sequencing: from conventional applications to breakthrough genomic analyses and precision oncology.
Demosthenes E Ziogas, Ioannis D Kyrochristos, Dimitrios H Roukos

Expert Rev Med Devices· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular landscape of pancreatic cancer: challenges and clinical implications.
Ioannis D Kyrochristos, Demosthenes E Ziogas, Georgios K Glantzounis, Dimitrios H Roukos

Future Oncol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary liver cancer genome sequencing: translational implications and challenges.
Demosthenes E Ziogas, Ioannis D Kyrochristos, Georgios K Glantzounis, Dimitrios Christodoulou, Evangelos Felekouras, Dimitrios H Roukos

Expert Rev Gastroenterol Hepatol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic heterogeneity: next-generation sequencing enables biomarker identification for hepatocellular carcinoma.
Demosthenes E Ziogas, Efstathios G Lykoudis, Dimitrios H Roukos, Georgios K Glantzounis

Biomark Med· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis